Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis

Area of Science:

• Hematology
• Oncology
• Medical Imaging

Background:

• Hematopoietic bone marrow and nonhematopoietic bone blood flow are critical physiological parameters.
• Chronic granulocytic leukemia (CGL) and primary myelofibrosis are hematologic malignancies affecting bone marrow function.
• Understanding bone blood flow dynamics is essential for diagnosing and managing these conditions.

Purpose of the Study:

• To measure and compare bone blood flow in patients with CGL and primary myelofibrosis against healthy controls.
• To investigate the relationship between bone marrow blood flow and disease phase in CGL.
• To determine the correlation between bone marrow cellularity and blood flow in these conditions.

Main Methods:

• Utilized the Xenon-133 (Xe-133) washout technique to measure blood flow.
• Included 20 patients with CGL, 7 patients with primary myelofibrosis, and age-matched healthy controls.
• Employed morphometric analysis to assess bone marrow cellularity.

Main Results:

• Bone marrow blood flow in CGL was significantly higher than in healthy controls, except during the initial disease phase.
• Blood flow varied with disease phase in CGL, being higher during the metamorphosis phase compared to the well-controlled phase.
• Increased bone blood flow was also observed in primary myelofibrosis, correlating with bone marrow cellularity in both diseases.

Conclusions:

• Bone marrow blood flow is elevated in CGL and primary myelofibrosis.
• Bone marrow blood flow is influenced by disease activity and cellularity in these hematologic disorders.
• The Xe-133 washout method provides valuable insights into bone marrow perfusion in myeloproliferative neoplasms.